Paul BarattieroDr. Paul Barattiero, Founder of EchoDr. Paul Barattiero is the founder of LumaNova and a leading advocate for performance-based red light therapy systems designed to support cellular health, recovery, and long-term vitality. With more than two decades of experience in the health and wellness industry, he focuses on advancing non-invasive technologies that enhance mitochondrial function, improve energy production, and optimize the body’s natural recovery processes.Through LumaNova, Dr. Paul develops photobiomodulation devices engineered to deliver clinically relevant wavelengths and power densities aligned with published research. His work centers on helping individuals, athletes, and wellness providers integrate red and near-infrared light therapy into practical, measurable health routines. By bridging consumer accessibility with professional-grade standards, he positions red light therapy as both a performance tool and a foundational wellness modality.Scientific literature on photobiomodulation underscores that therapeutic benefit is dose-dependent. The biological response to red and near-infrared light is influenced by wavelength specificity, irradiance, exposure time, and cumulative energy delivery. Peer-reviewed studies suggest that when light is delivered within established parameters, it may support:• Enhanced mitochondrial ATP production and cellular energy output• Reduction in oxidative stress and inflammatory markers• Improved muscle recovery and tissue repair• Increased circulation and collagen support for skin health• Circadian rhythm alignment and sleep quality• Cognitive clarity and mood regulationResearch consistently emphasizes that precision matters. Effective photobiomodulation requires consistent wavelength accuracy and controlled irradiance levels to align with validated photobiological standards. This research-driven approach informs the development philosophy behind LumaNova systems and distinguishes clinically aligned devices from commodity wellness lighting products.Learn more about your ad choices. Visit megaphone.fm/adchoices